The Role of Peptides and Peptidomimetics in Drug Discovery
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 33
Special Issue Editor
Interests: organic chemistry; medicinal chemistry; small molecules; drug-like compounds; tethered and fused diazacyclic compounds; heterocyclic peptidomimetics; combinatorial chemistry; solid phase organic synthesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Peptide and Peptidomimetic drug discovery has progressed tremendously over the last two decades to become an extraordinary field which has resulted in a substantial body of multidisciplinary research. It has engaged synthetic, computational, and biophysical chemists, biochemists, pharmacologists, and drug development scientists worldwide to create novel molecule lead compounds, clinical candidates, and breakthrough medicines. Immense efforts have been dedicated towards developing therapeutic entities that can modulate intracellular proteins. Molecules that can readily cross cell membranes are becoming a frequent need in biological research, drug discovery, and medicine. A wide variety of natural peptides and peptidomimetics have been obtained and studied, and many others are advancing through clinical trials, covering multiple therapeutic areas.
Taking advantage of the diversity within the amino acid functionalities and stereochemistry that are commercially available as standard Fmoc/Boc amino acids, as well as the benefits of solid phase peptide synthesis, various synthetic strategies have been developed over the years to modulate the conformational flexibility and the peptide character of peptidomimetic compounds. This Special Issue calls for papers to elucidate the most effective strategy for the synthesis of peptides, cyclic peptides, and peptidomimetics, and the use of such approaches in the identification of active therapeutics with peptide structures.
Prof. Dr. Adel Nefzi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptide synthesis
- peptide therapeutics
- cyclic peptides
- peptidomimetics
- peptide drug discovery
- modified peptides
- bioactive peptides
